Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: A 10-year follow-up study
- 1 February 2014
- journal article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 43 (4) , 558-565
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Libman-Sacks Endocarditis in Systemic Lupus Erythematosus: Prevalence, Associations, and EvolutionThe American Journal of Medicine, 2007
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- An Echocardiographic Study of Valvular Heart Disease Associated with Systemic Lupus ErythematosusNew England Journal of Medicine, 1996
- Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valvesLupus, 1996
- Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patientsThe American Journal of Medicine, 1994
- Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodiesJACC, 1992
- Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies.Circulation, 1990
- Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosusThe Lancet, 1990
- Prevalence, Morphologic Types, and Evolution of Cardiac Valvular Disease in Systemic Lupus ErythematosusNew England Journal of Medicine, 1988
- Immunopathogenesis of Libman-Sacks endocarditis. Assessment by light and immunofluorescent microscopy in two patients.Annals of the Rheumatic Diseases, 1977